Dimethyl Sulfoxide → HCID 20816861, compound
Reaction equation
[F:1][C:2]1[CH:30]=[CH:29][C:5]([CH2:6][NH:7][C:8]([C:10]2[C:19]([OH:20])=[C:18]3[C:13]([CH:14]=[CH:15][CH:16]=[N:17]3)=[C:12]([CH:21]3[S:27][CH2:26][CH2:25][NH:24][C:23](=[O:28])[CH2:22]3)[N:11]=2)=[O:9])=[CH:4][CH:3]=1.ClC1C=CC=C(C(OO)=[O:39])C=1.ClCCl.CS(C)=O>CN(C=O)C.C(OCC)C>[F:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][NH:7][C:8]([C:10]2[C:19]([OH:20])=[C:18]3[C:13]([CH:14]=[CH:15][CH:16]=[N:17]3)=[C:12]([CH:21]3[S:27](=[O:39])[CH2:26][CH2:25][NH:24][C:23](=[O:28])[CH2:22]3)[N:11]=2)=[O:9])=[CH:29][CH:30]=1Participants
7
Procedure
To a cold (0° C.) solution of N-(4-fluorobenzyl)-8-hydroxy-5-(5-oxo-1,4-thiazepan-7-yl)[1,6]naphthyridine-7-carboxamide (Example 141) (0.22 g, 0.52 mmol) in DMF (25 mL), a solution of 3-chloroperbenzoic acid in dichloromethane (0.57 mmol, 0.129 g/mL) was added and stirred at room temperature for 2 hours. The product mixture was treated with DMSO (1 mL), diethyl ether (200 mL), and cooled in an ice bath. The resultant precipitate was filtered, dissolved in DMSO, and subjected to HPLC purification on C-18 stationary phase eluted with water/acetonitrile/TFA mobile phase. Collection and lyophilization of appropriate fractions provided the title compound.
Workup
- temperaturecooled in an ice bath
- filtrationThe resultant precipitate was filtered
- dissolutiondissolved in DMSO
- customsubjected to HPLC purification on C-18 stationary phase
- washeluted with water/acetonitrile/TFA mobile phase
- customCollection and lyophilization of appropriate fractions
Sources & evidence
- ORD record
- ord-d8d0b6d79e004d2eb7ef2f43100c6226
- Source dataset
- uspto-grants-2005_07
- Patent number
- US06921759B2
Reaction notes
Loading…